Neurocrine Bioscience buy Guggenheim
Start price
02.08.24
/
50%
€140.30
Target price
02.08.25
€164.90
Performance (%)
0.00%
Price
02.08.24
€140.30
Summary
This prediction is currently active. Guggenheim's BUY prediction for Neurocrine Bioscience is currently unchanged. This prediction currently runs until 02.08.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | 0.00% |
iShares Core DAX® | -3.935% |
iShares Nasdaq 100 | -3.608% |
iShares Nikkei 225® | -4.513% |
iShares S&P 500 | -2.607% |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Guggenheim from $170.00 to $180.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€158.42
02.05.25
02.05.25
6.90%
02.08.24
02.08.24